Clinical Trials on Charcot-Marie-Tooth Type 1A

Total 1408 results

The University of Hong Kong-Shenzhen Hospital

Completed

Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital

Unknown

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Yuan-hong Gao

Completed

Late Sequelae of Childhood and Adolescent Nasopharyngeal Carcinoma Survivors After Radiotherapy

Nasopharyngeal Carcinoma
Yun-fei Xia

Unknown

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

Nasopharyngeal Carcinoma

China
Pamela Youde Nethersole Eastern Hospital

Completed

NBI to Detect Post-RT Mucosal Residual NPC

Nasopharyngeal Carcinoma

Hong Kong
Taichung Veterans General Hospital

Unknown

Effect of the Plasma EBV DNA Change During Chemoradiotherapy in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Taiwan
Washington University School of Medicine
National Comprehensive Cancer Network

Completed

GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer

Mouth Neoplasms | Neoplasms, Oral

United States
Sun Yat-sen University

Unknown

Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Unknown

Phase II Trial of TIL Following CCRT in Patients With Locoregionally Advanced NPC (TIL)

Nasopharyngeal Carcinoma

China
Capital Medical University
Beijing Friendship Hospital; Cancer Institute and Hospital, Chinese Academy...

Unknown

Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Unknown

Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
Sun Yat-sen University
Chinese Southwest Oncology Group

Unknown

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sanofi

Completed

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Carcinoma | Nasopharyngeal Neoplasms

France, Korea, Republic of, Turkey, Algeria, Brazil, China, India, Indonesia, Italy, Mexico, Morocco, Philippines, Thailand, Tunisia
Betta Pharmaceuticals Co., Ltd.

Unknown

A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
He Xia

Unknown

Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma (NPC-RCT-WCRT)

Nasopharyngeal Carcinoma
Cancer Institute and Hospital, Chinese Academy...

Completed

The Role of Induction Chemotherapy for High-risk Locally Advanced Nasopharyngeal Carcinoma in the Era of IMRT

Nasopharyngeal Neoplasms

China
Fudan University

Terminated

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
First People's Hospital of Foshan

Unknown

The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
First People's Hospital of Foshan

Unknown

Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Zhejiang Cancer Hospital

Unknown

Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Unknown

Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma (ABX-DDP-Dose)

Nasopharyngeal Neoplasms

China
Hospital Authority, Hong Kong
Hong Kong Nasopharyngeal Cancer Study Group Limited

Unknown

Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

China
Zhejiang Cancer Hospital
Wenzhou Medical University; Second Affiliated Hospital, School of Medicine,... and other collaborators

Unknown

Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma (ESNCCT)

Nasopharyngeal Carcinoma | Chemoradiation

China
Fudan University

Unknown

Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer

Nasopharyngeal Carcinoma

China
Guangxi Medical University
Liuzhou Workers Hospital; Wuzhou Red Cross Hospital; Guilin Medical College; People... and other collaborators

Unknown

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sanofi

Completed

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Hong Kong
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; Taipei Veterans... and other collaborators

Terminated

A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients

Nasopharyngeal Carcinoma

Taiwan
Fudan University

Unknown

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) (TPF for NPC)

Nasopharyngeal Carcinoma

China
Fudan University

Unknown

Study of Concurrent Chemotherapy and Radiotherapy for Stage II Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fudan University

Unknown

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University
First Affiliated Hospital, Sun Yat-Sen University; Tongji Hospital; Hunan Cancer... and other collaborators

Recruiting

Reduced-dose RT With/Without CCT Versus Standard CCRT for High-risk LANPC Who Achieved CR Post Induction Chemotherapy

Nasopharyngeal Carcinoma | De-escalation Therapy

China
Zhongshan People's Hospital, Guangdong, China
Sun Yat-sen University Cancer Centre

Recruiting

Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma (CTVp1-NPC)

Nasopharyngeal Carcinoma | Intensity-Modulated Radiotherapy

China
University of Miami

Not yet recruiting

Feasibility of Adaptive Radiation Therapy for Human-papilloma Virus-positive Oropharyngeal Cancer Patients on MRIdian Linac (OPC-V)

Oropharynx Cancer

United States
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

A Clinical Study to Evaluate the Safety and Tolerability of JS001sc in Advanced Nasopharyngeal Carcinoma

Advanced Nasopharyngeal Carcinoma

China
Affiliated Cancer Hospital & Institute of Guangzhou...
Hunan Cancer Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Not yet recruiting

Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

Metastatic Nasopharyngeal Carcinoma
Chinese Academy of Sciences
Sun Yat-sen University; Fujian Cancer Hospital; Guangdong Provincial People's... and other collaborators

Recruiting

Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images

Nasopharyngeal Carcinoma | Image-Guided Biopsy

China
University of Coimbra
Instituto de Investigación Biomédica de Salamanca

Not yet recruiting

Myofascial Pain Patients' Response to the Administration of Low Doses of Amitriptyline and Citalopram Compared With the Use of Bite Splint

Muscle Type Temporomandibular Disorders | Myofascial Pain of the Masticatory Muscles

Portugal
Zhejiang Cancer Hospital

Recruiting

PET/MR in Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | PET/MR

China
Jiangxi Provincial Cancer Hospital
Sixth Affiliated Hospital, Sun Yat-sen University

Not yet recruiting

Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal Carcinoma

Injury; Temporal Region
Zeng Changhao

Terminated

Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Center Eugene Marquis

Completed

Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (ARTIX)

Oropharynx Cancer

France
National Cancer Centre, Singapore
Singapore General Hospital; A*Star

Completed

Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer

Nasopharyngeal Carcinoma

Singapore
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Refractory Nasopharyngeal Carcinoma

Singapore
Emory University
Sanofi

Terminated

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

Oral Cancer | Squamous Cell Carcinoma

United States
University of Liverpool
Cancer Research UK; Liverpool University Hospitals NHS Foundation Trust; Advaxis... and other collaborators

Terminated

Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer (REALISTIC:)

HPV-16 +ve Oropharyngeal Carcinoma

United Kingdom
China Medical University Hospital
Ministry of Health and Welfare, Taiwan

Unknown

Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma

Oral Squamous Cell Carcinoma

Taiwan
Biotech Pharmaceutical Co., Ltd.

Unknown

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Nasopharyngeal Cancer

China
Cancer Hospital of Guangxi Medical University

Unknown

The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma

Effects of Chemotherapy

China
University of Chile

Completed

Effects of Periodontal Therapy on Systemic Inflammation

Obesity | Cardiovascular Disease | Metabolic Syndrome | Type 2 Diabetes | Periodontal Disease

Chile
Centre Leon Berard

Not yet recruiting

Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO) (TACO)

Oral Squamous Cell Carcinomas

France

Clinical Trials on Charcot-Marie-Tooth Type 1A

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations